Clinical Trials
2 trialsNCT03127449 2025-04-03
AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Allist Pharmaceuticals, Inc.
Phase NA Terminated
NCT05106335 2023-08-16
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Terminated